All In Biotech

Drug Trial Radar · NCT06969664

A Trial of SHR7280 in Healthy Subjects

A Phase I Clinical Study to Evaluate Effect of High-Fat Diet on Pharmacokinetics of a Single Oral Dose of SHR7280 Tablets and to Assess the Effect of SHR7280 on QT Interval in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: Aug 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

16

Actual

Start

May 19, 2025

Primary completion

Jul 5, 2025

Study completion Jul 5, 2025

Sponsor

Sponsor type
Industry
First posted
May 14, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The study is being conducted to evaluate the effect of high-fat meal on pharmacokinetics of SHR7280 after oral administration and the effect of SHR7280 on QT interval at low and high doses in healthy Chinese volunteers.

Conditions

  • Endometriosis
  • Uterine Fibroids
  • Assisted Reproduction

Interventions

  • SHR7280 TabletDrug

    Oral SHR7280 tablet.

  • SHR7280 Placebo TabletDrug

    Oral SHR7280 placebo tablet.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Peak concentration (Cmax)Time frame: Day 1 to Day 8.
  2. Area under the plasma concentration-time curve from time 0 to the last quantifiable timepoint (AUC0-t)Time frame: Day 1 to Day 8.
  3. Area under the plasma concentration-time curve from time 0 to infinity (AUC0-∞)Time frame: Day 1 to Day 8.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.